Lisa: Josh, as a partner in Boyden UK’s Interim Management Practice, can you tell us about your focus and priorities.
Josh: First, I am so pleased to have joined the Boyden UK & Ireland team and I am excited about working in such a respected international business. Second, and to answer your question, my focus will span Healthcare & Life Sciences in the appointment of interim board, c-suite and senior change managers with national, multi-national and international businesses. Our area of expertise is working with small to mid-capital businesses, both private and public, who are going through significant periods of growth. This growth may come about from initial seed money, Series A or B, or expanding internationally. We also have a strong footprint with established PLCs.
Lisa: How do you manage your clients’ need for both Permanent and Interim Executives to support their businesses?
Josh: As a result of Boyden’s fully integrated executive search, interim management and leadership consulting service lines, I work closely with my colleague Nick Bellwood, Partner. Nick is responsible for our executive search offering in Healthcare & Life Sciences where we will complement each other when supporting our client’s requirements. It can be a burdensome process for some clients due to pressures on their diaries so to have both service lines working closely together eases the process, allowing them to focus on the needs of their business.
Lisa: What do you see as the key challenges and opportunities within the UK Healthcare & Life Sciences sector for 2022?
Josh: As a sector, workforce supply issues have typically been the pressure point facing many healthcare & life science businesses over recent years and the ‘burnout’ of staff from Covid-19, specific to healthcare, has compounded this to create unseen levels of vacancies. This has resulted in demand for senior interim managers, either to fill short-term gaps or to create strategies for recruitment and retention.
